IGF-1 DES removes the first three (glycine-proline-glutamate), leaving a 67-amino-acid peptide
Results, safety, and dosing remain unproven in human populations
READ the full study in RAPM: #PhantomLimbPain #Cryoneurolysis #PainMedicine #RegionalAnesthesia #ClinicalResearch #Innovation To view or add a comment, sign in Ophthopedia Update:Mitomycin C in Non-Endoscopic Endonasal Dacryocystorhinostomy: A Randomized Clinical Trial involving 442 cases: Mitomycin C (MMC) is used as an adjuvant in endonasal endoscopic dacryocystorhinostomy (EN-DCR) despite the existing heterogeneity in the literature on the concentration, duration of application, indication and outcomes
This route is common for established joint treatments like corticosteroids and hyaluronic acid, suggesting feasibility for clinical application
Its high purity guarantees accurate results and minimizes potential interference during testing, supporting cutting-edge explorations in peptide research
Fast, Effective Local Anesthetic for Medical & Dental Procedures
